Article
Resistance to direct antiviral agents in patients with hepatitis C virus infection.
Gastroenterology - 1 Feb 2010
Sarrazin Christoph, Zeuzem Stefan
Abstract excerpt
Chronic hepatitis C virus (HCV) infection is one of the major causes of cirrhosis, hepatocellular carcinoma, and liver failure that leads to transplantation. The current standard treatment, a combination of pegylated interferon alfa and ribavirin, eradicates the virus in only about 50% of patients. Directly acting antiviral (DAA) agents, which inhibit HCV replication, are in phase 1, 2, and 3 trials; these...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
